InvestorsHub Logo
Followers 12
Posts 1099
Boards Moderated 0
Alias Born 06/07/2018

Re: Tanis2476 post# 5230

Sunday, 09/30/2018 10:43:18 PM

Sunday, September 30, 2018 10:43:18 PM

Post# of 5918
You can't make this stuff up!

The CBD content may be 98% pure CBD, but Epidiolex is described on Google Patents as not just containing CBD, because CBD by itself is unpatentable since it's a plant extract or an isolate. The CBD may be 98% pure, but Epidiolex is not 98% CBD. There is a difference:

Source:
Google Patents: Use of cannabidiol in the treatment of epilepsy

[0055] In accordance with a third aspect of the present invention there is provided a composition for use in the treatment of epilepsy characterised by absence seizures comprising cannabidiol (CBD), a solvent, a co-solvent, a sweetener, and a flavouring.

[0056] Preferably the solvent is sesame oil, the co-solvent is ethanol, the sweetener is sucralose, the flavouring is strawberry flavour and the CBD is present at a concentration of between 25/mg/ml and 100 mg/ml, namely 50mg/ml and 75 mg/ml.

[0057] More preferably the composition comprises cannabidiol (CBD) at a concentration of between 25 to 100 mg/ml, ethanol at a concentration of 79 mg/ml, sucralose at a concentration of 0.5 mg/ml, strawberry flavouring at a concentration of 0.2 mg/ml and sesame oil q.s. to 1.0ml.

[0058] It is envisaged that the composition be administered as an oral liquid solution. Other modes of administration including solids, semi-solids, gels, sprays, aerosols, inhalers, vaporisers, enemas and suppositories are alternative administration forms. Such medicaments could be administered via the oral, buccal, sublingual, respiratory, nasal and distal rectum route.



---------------------------------------------------------------------------

Source 2:
To Patent or Not To Patent: Are Natural Products Off the Table?

No longer will the often tedious and expensive processes of isolating, purifying, or even synthesizing a natural product afford patent eligibility.



---------------------------------------------------------------------------

My Take:

GWPH didn't gain a patent on CBD like they would have you believe. They gained a patent on a concoction that contains CBD that is 98% pure, yet Epidiolex is not 98% CBD! Read the patent yourself. Initial cost estimates for the use of Epidiolex is $2,500 to $5,000 per month. A bottle from CVSI only costs around $50.

You can't make this stuff up! This is another reason why hemp CBD extracts won't be condemned to the Schedule V fate of Epidiolex.

PS:

Why CVSI isn't breaking the law